Role of melatonin receptor MT2 and quinone reductase II in the regulation of the redox status of 3T3-L1 preadipocytes in vitro

We have examined the role of melatonin receptor MT2 and quinone reductase II in the regulation of the redox status of preadipocytes (3T3-L1) in vitro. 3T3-L1 cells were treated with melatonin at a physiological concentration (10(-9)mol/L) and a supraphysiological (pharmacological) concentration (10(-3)mol/L) for 24h. Luzindole (10(-4)mol/L), an antagonist of MT2 receptor, and prazosin (10(-5)mol/L), an inhibitor of quinone reductase II, were added 30min before subsequent exposure of the cells to melatonin. The level of oxidative stress was determined by the analysis of activities of enzymes neutralising reactive oxygen species, and determination of the malondialdehyde (MDA) content. Melatonin increased activities of manganese and copper-zinc superoxide dismutase (MnSOD, Cu/ZnSOD) and catalase (CAT) at both a physiological concentration (10(-9)mol/L) and a pharmacological concentration (10(-3)mol/L). MDA content was unchanged, whereas activities of glutathione peroxidase (GSH-Px) and glutathione reductase (GSSG-Rd) were increased only by the physiological concentration. Both effects were partially inhibited by luzindole, but not prazosin. These observations suggest that melatonin, acting at least partially via MT2 receptors, can increase antioxidant enzymes activities in 3T3-L1 preadipocytes.